Relivion® Wearable Brain Neuromodulation Technology Cleared by FDA for the Treatment of Migraine

Relivion is the first non-invasive multi-channel brain neuromodulation system for at home treatment of acute migraine, a debilitating neurological disease impacting 39 million people and resulting in 1.2 million emergency department visits annually.